![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 21, 22571-22577, May 21, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶

From the
Department of Medicine, ||Department of Biomedical Engineering, and
Program in Genetics, State University of New York at Stony Brook, Stony Brook, New York 11794-8151
Circulating blood platelets regulate the initial phase of the hemostatic response through adhesive and aggregatory events and by providing the necessary procoagulant surface for prothrombinase complex assembly and thrombin generation. The signaling pathway(s) that regulate platelet procoagulant activity are largely unknown, although they are distinct from platelet aggregatory signals linked to fibrinogen ligation to the conformationally active
IIB
3 integrin. We describe a novel intracellular signaling mechanism involving platelet IQGAP1 that specifically regulates the development of platelet procoagulant activity under conditions of mechanical shear stress. Murine platelets that are deficient in IQGAP1 demonstrate increased prothrombinase activity compared with wild-type littermate controls when activated by a physiological shear stress of 16 dynes/cm2 (shear rates of 1600 s-1) (p < 0.0001), corresponding to
2.5 times the normal shear stress, or
40% degree of stenosis in coronary arteries. The exaggerated prothrombinase activity is not associated with enhanced platelet microvesiculation (cytoskeletal proteolysis) and occurs independently of the intracellular calcium release, [Ca2+]i, but it is specifically coupled to the
-granule exocytic pathway without concomitant effects on aminophospholipid exposure. These observations identify platelet IQGAP1 as an important modulator of normal hemostasis and as an appropriate pharmacological target for control of platelet procoagulant function.
Received for publication, March 8, 2004 , and in revised form, March 15, 2004.
* This work was supported by Grants HL49141 and HL53665 National Institutes of Health and a Veterans Affairs Research Enhancement Award Program award (to W. F. B.) and Center Grant M01 10710-5 N.I.H. to the University Hospital General Clinical Research Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Division of Hematology, Health Sciences Center T15-040, State University of New York, Stony Brook, NY 11794-8151. Tel.: 631-444-2059; Fax: 631-444-7530; E-mail: wbahou{at}notes.cc.sunysb.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. A. Schmidt, C. S. Chiariello, E. Capilla, F. Miller, and W. F. Bahou Development of Hepatocellular Carcinoma in Iqgap2-Deficient Mice Is IQGAP1 Dependent Mol. Cell. Biol., March 1, 2008; 28(5): 1489 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Kerrigan, N. S. Jakubovics, C. Keane, P. Maguire, K. Wynne, H. F. Jenkinson, and D. Cox Role of Streptococcus gordonii Surface Proteins SspA/SspB and Hsa in Platelet Function Infect. Immun., December 1, 2007; 75(12): 5740 - 5747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hathcock Flow Effects on Coagulation and Thrombosis Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1729 - 1737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |